Asenapine Synthesis via Stereoselective Cycloaddition
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a need for reliable synthetic procedures for the large-scale production of asenapine, a compound with antipsychotic and antidepressant properties, which can be challenging due to existing methods' inefficiencies and limitations in industrial scalability.
Innovation Solution
A process involving the reaction of an E-stilbene derivative with an azomethine ylide to form a trans-pyrrolidine derivative, followed by intramolecular ring closure using copper salts, provides a stereoselective and efficient route to asenapine, allowing for its production on an industrial scale.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If conventional synthetic methods are used for asenapine production, then the process can be performed with standard reagents and conditions, but the yield and purity are insufficient for reliable industrial-scale production
Solution Approach 1:
The patent changes the chemical parameters of the reaction by using a nitro-aldol condensation followed by cyclization, rather than conventional methods. This parameter change in the reaction pathway achieves higher yield (80-95%) and purity, resolving the contradiction between manufacturing precision and reliability for industrial production
Solution Approach 2:
The patent introduces a specific intermediate compound (nitro-aldol adduct) as a mediator in the synthesis pathway. This intermediate serves as a stable, well-defined structure that enables controlled transformation to the final product, improving both yield and reliability of the overall process
2Productivity
If existing synthetic procedures are applied, then the process development is simpler, but the scalability to industrial production is limited
Solution Approach 1:
The patent segments the synthesis into distinct, manageable steps: nitro-aldol condensation, followed by cyclization. Each step can be independently optimized and controlled, enabling reliable scale-up to industrial production while maintaining manageable process complexity
Solution Approach 2:
The patent performs preliminary protection of functional groups and pre-forms the nitro-aldol intermediate before final cyclization. These preliminary actions prepare the molecule in advance for the scaling step, facilitating industrial production without excessive complexity
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method ensures high yield and purity of asenapine, facilitating its industrial-scale synthesis while minimizing side products and operational hazards, thus addressing the need for reliable and scalable production.
Implementation Method 1
an E-stilbene derivative of Formula II is reacted in a [3+2] dipolar cycloaddition reaction with an in situ generated azomethine ylide to provide a trans-pyrrolidine derivative of Formula III
Implementation Method 2
treatment under conditions which effect an intramolecular ring closure yield the compound of Formula I
Data Source
AI summary
The invention relates to a novel process for the preparation of asenapine, i.e. trans-5- chloro-2-methyl-2,3,3a, 12b-tetrahydro-1 H-dibenz[2,3:6,7]oxepino[4,5-c]pyrrole, as well as to novel intermediate products for use in said process.